HER2 Antibodies Market Opportunities, Forecast, Size, Competitive Analysis till 2031

Coverage: HER2 Antibodies Market covers analysis By Type (Trastuzumab, Lapatinib, Ado-trastuzumab emtansine, Pertuzumab, Everolimus), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00007432
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

The HER2 Antibodies Market is expected to register a CAGR of 5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The global HER2 Antibodies market research report is segmented by type into the following subsegments: Trastuzumab, Lapatinib, Ado-trastuzumab Emtansine, Pertuzumab, and Everolimus. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report HER2 Antibodies Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

HER2 Antibodies Market Segmentation

Type
  • Trastuzumab
  • Lapatinib
  • Ado-trastuzumab emtansine
  • Pertuzumab
  • Everolimus

Strategic Insights

HER2 Antibodies Market Growth Drivers
  • Rising Incidence of HER2-Positive Cancers: The increasing incidence of HER2-positive cancers, particularly breast cancer, is driving the demand for HER2 antibodies as targeted therapies.
  • Advancements in HER2 Antibody Development: The development of newer, more effective HER2 antibodies with better efficacy and safety profiles, driven by biotechnology and pharmaceutical research, is boosting market growth.
  • Personalized Medicine and Targeted Therapies: Growing awareness and knowledge of personalized medicine and targeted therapies are fueling the demand for HER2 antibodies, as both healthcare providers and patients recognize their benefits.
HER2 Antibodies Market Future Trends
  • Biosimilars Increasing Competition and Accessibility: The rise of biosimilars for HER2 antibodies will increase competition, lower treatment costs, and make these therapies more accessible to a broader patient population.
  • Combination Therapies with Immunotherapy: Combining HER2 antibodies with other therapeutic interventions, such as immunotherapy, is a promising area of research, potentially improving treatment efficiency for patients with advanced HER2-positive cancers.
  • Advancing Cancer Biology and Targeted Therapies: As the need to better understand cancer biology and targeted therapies grows, the HER2 antibodies market is poised for significant advancements in patient care and survival outcomes.
HER2 Antibodies Market Opportunities
  • Research Advancements in HER2 Targeting for Various Cancers: Ongoing research into the potential of HER2 targeting across different cancer types will drive significant market growth as new applications are discovered.
  • Personalized Medicine and Biomarker-Driven Therapies: The growing emphasis on personalized medicine and biomarker-driven therapies provides opportunities for developing companion diagnostic tests, tailoring HER2 treatments to individual patients for optimized outcomes.
  • Optimizing Treatment and Quality of Life: Tailored treatments based on diagnostic tests will improve patient outcomes, focusing on the most effective therapies while prioritizing quality of life.

Market Report Scope

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the HER2 Antibodies Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the HER2 Antibodies Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


RD Image
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
REGIONAL FRAMEWORK
World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the deliverable formats of the HER2 Antibodies Market?report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report? 

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Which are the leading players operating in the HER2 Antibodies Market?

The leading players of te market are: B. Braun Melsungen AG, Bovie Medical Corporation, Conmed Ethicon Endo-Surgery, Karl Storz, KLS Martin, Maxer Endoscopy GmbH, Medical Technologies, Medtronic, Olympus Corporation

What are the future trends of the HER2 Antibodies Market?

Future Outlook The HER2 Antibodies Market continues to be optimistic, with wide-ranging trends influencing its future. One of the most significant trends is that of innovative efficacy combined with lesser toxicity of ADCs that the new generation of HER2 antibody-drug conjugates will incorporate. Biosimilars for HER2 antibodies are also expected to gain market place and increase competition, thus cutting costs. Significant in the HER2 antibodies field is the integration with other therapeutic modalities for example, immunotherapy. Through a constantly increasing understanding of cancer biology and the targeted therapies, the future is promising for improving patient care and survival rates in the HER2 Antibodies market.

What is the expected CAGR of the HER2 Antibodies Market?

HER2 Antibodies Market is expected to grow at a CAGR of 5% between 2023-2031

What are the driving factors impacting the HER2 Antibodies Market?

The demand for HER2 Antibodies has been driven by several key drivers. There is an increasing incidence of HER2-positive cancers, predominantly breast cancers. Biotechnology and pharmaceuticals have developed novel HER2 antibodies with increased efficacy and a diminished safety profile. Awareness of personalized medicine and targeted therapies is another cause that drives the market forward. Moreover, government support policies and favorable reimbursement policies for cancer therapies also boost the market.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 HER2 Antibodies Market - By Type
1.3.2 HER2 Antibodies Market - By Region
1.3.2.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. HER2 ANTIBODIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. HER2 ANTIBODIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. HER2 ANTIBODIES MARKET - GLOBAL MARKET ANALYSIS
6.1. HER2 ANTIBODIES - GLOBAL MARKET OVERVIEW
6.2. HER2 ANTIBODIES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. HER2 ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. TRASTUZUMAB
7.3.1. Overview
7.3.2. Trastuzumab Market Forecast and Analysis
7.4. LAPATINIB
7.4.1. Overview
7.4.2. Lapatinib Market Forecast and Analysis
7.5. ADO-TRASTUZUMAB EMTANSINE
7.5.1. Overview
7.5.2. Ado-trastuzumab emtansine Market Forecast and Analysis
7.6. PERTUZUMAB
7.6.1. Overview
7.6.2. Pertuzumab Market Forecast and Analysis
7.7. EVEROLIMUS
7.7.1. Overview
7.7.2. Everolimus Market Forecast and Analysis
8. HER2 ANTIBODIES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America HER2 Antibodies Market Overview
8.1.2 North America HER2 Antibodies Market Forecasts and Analysis
8.1.3 North America HER2 Antibodies Market Forecasts and Analysis - By Type
8.1.4 North America HER2 Antibodies Market Forecasts and Analysis - By Countries
8.1.4.1 United States HER2 Antibodies Market
8.1.4.1.1 United States HER2 Antibodies Market by Type
8.1.4.2 Canada HER2 Antibodies Market
8.1.4.2.1 Canada HER2 Antibodies Market by Type
8.1.4.3 Mexico HER2 Antibodies Market
8.1.4.3.1 Mexico HER2 Antibodies Market by Type
8.2. EUROPE
8.2.1 Europe HER2 Antibodies Market Overview
8.2.2 Europe HER2 Antibodies Market Forecasts and Analysis
8.2.3 Europe HER2 Antibodies Market Forecasts and Analysis - By Type
8.2.4 Europe HER2 Antibodies Market Forecasts and Analysis - By Countries
8.2.4.1 Germany HER2 Antibodies Market
8.2.4.1.1 Germany HER2 Antibodies Market by Type
8.2.4.2 France HER2 Antibodies Market
8.2.4.2.1 France HER2 Antibodies Market by Type
8.2.4.3 Italy HER2 Antibodies Market
8.2.4.3.1 Italy HER2 Antibodies Market by Type
8.2.4.4 Spain HER2 Antibodies Market
8.2.4.4.1 Spain HER2 Antibodies Market by Type
8.2.4.5 United Kingdom HER2 Antibodies Market
8.2.4.5.1 United Kingdom HER2 Antibodies Market by Type
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific HER2 Antibodies Market Overview
8.3.2 Asia-Pacific HER2 Antibodies Market Forecasts and Analysis
8.3.3 Asia-Pacific HER2 Antibodies Market Forecasts and Analysis - By Type
8.3.4 Asia-Pacific HER2 Antibodies Market Forecasts and Analysis - By Countries
8.3.4.1 Australia HER2 Antibodies Market
8.3.4.1.1 Australia HER2 Antibodies Market by Type
8.3.4.2 China HER2 Antibodies Market
8.3.4.2.1 China HER2 Antibodies Market by Type
8.3.4.3 India HER2 Antibodies Market
8.3.4.3.1 India HER2 Antibodies Market by Type
8.3.4.4 Japan HER2 Antibodies Market
8.3.4.4.1 Japan HER2 Antibodies Market by Type
8.3.4.5 South Korea HER2 Antibodies Market
8.3.4.5.1 South Korea HER2 Antibodies Market by Type
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa HER2 Antibodies Market Overview
8.4.2 Middle East and Africa HER2 Antibodies Market Forecasts and Analysis
8.4.3 Middle East and Africa HER2 Antibodies Market Forecasts and Analysis - By Type
8.4.4 Middle East and Africa HER2 Antibodies Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa HER2 Antibodies Market
8.4.4.1.1 South Africa HER2 Antibodies Market by Type
8.4.4.2 Saudi Arabia HER2 Antibodies Market
8.4.4.2.1 Saudi Arabia HER2 Antibodies Market by Type
8.4.4.3 U.A.E HER2 Antibodies Market
8.4.4.3.1 U.A.E HER2 Antibodies Market by Type
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America HER2 Antibodies Market Overview
8.5.2 South and Central America HER2 Antibodies Market Forecasts and Analysis
8.5.3 South and Central America HER2 Antibodies Market Forecasts and Analysis - By Type
8.5.4 South and Central America HER2 Antibodies Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil HER2 Antibodies Market
8.5.4.1.1 Brazil HER2 Antibodies Market by Type
8.5.4.2 Argentina HER2 Antibodies Market
8.5.4.2.1 Argentina HER2 Antibodies Market by Type
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

10. HER2 ANTIBODIES MARKET, KEY COMPANY PROFILES
10.1. ABNOVA CORPORATION
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. ACTAVIS
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. BIOCON LIMITED,
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. BIO-TECHNE (NOVUS BIOLOGICALS, LLC)
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. CELLTRION, INC.
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. GENENTECH INC. (F. HOFFMANN-LA ROCHE LTD.)
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. GREEN CROSS
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. INVIVOGEN
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. NOVARTIS AG
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. PFIZER, INC.
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
The List of Companies

1. Abnova Corporation
2. Actavis
3. Biocon Limited,
4. Bio-Techne (Novus Biologicals, LLC)
5. Celltrion, Inc.
6. Genentech Inc. (F. Hoffmann-La Roche Ltd.)
7. Green Cross
8. InvivoGen
9. Novartis AG
10. Pfizer, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..